Company Active LTD

Company profile

Ampersand Health Limited

Ampersand Health: Digital Therapy for Inflammatory Conditions

We are a social purpose company founded by doctors and patients to improve the health and happiness of people with long term inflammatory conditions.

CRN
11584266
Founded
2018
Age
7

Overview

Legal name
AMPERSAND HEALTH LIMITED
Region
Unknown
Registered address
14 AMHERST AVENUE
LONDON
ENGLAND
W13 8NQ
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

8 events
28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

07 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

23 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May
2025

Accounts filed

Accounts

Last accounts made up date

01 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNzk4NTg3M2FkaXF6a2N4

Published 01 Oct 2024 03:48

01 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNzk4NDg3N2FkaXF6a2N4

Published 01 Oct 2024 03:38

03 Sep
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzNDMyNjkxMmFkaXF6a2N4

Published 03 Sep 2024 15:48

24 Sep
2018

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2019
Funded years
2019, 2020
Age at first award
0 years

Projects

2020 Feasibility Studies Lead participant

Improving Out of Hospital Care, In Crisis and After: A digital approach to improving supported self management and remote monitoring for the at risk.

1 Jun 2020 to 28 Feb 2021

Awarded
£74,863
Total cost £74,863

This project seeks to develop a novel behavioural science based self-care intervention for people living with inflammatory arthritis. The intervention has three components - an (existing) technology stack, a behavioural science framework and evidence-based content modules developed with leading experts from the NHS. The extension for Impact funding will e...

2020 Feasibility Studies Lead participant

Request for funding to secure viability of delayed clinical trial

1 Jun 2020 to 30 Nov 2020

Awarded
£44,478
Total cost £44,478

no public description

2019 Collaborative R&D Lead participant

Ampersand Health Digital Therapeutics Platform

1 Jul 2019 to 31 Mar 2021

Awarded
£91,775
Total cost £183,550

Ampersand Health is a social enterprise that's developing the first clinically validated digital therapeutic for people with long term inflammatory conditions. Our intervention helps patients take greater control of their own care by providing them with actionable information therapy via a mobile application; and allows clinical teams to monitor their con...

Product types

Collaborative R&D Feasibility Studies